Work

MCL1 inhibition exerts potent antileukemic activity by restoring apoptosis in T-lineage acute lymphoblastic leukemia

Year: 2026

Type: article

Source: Blood Neoplasia

DOI: 10.1016/j.bneo.2026.100302

Authors: Giorgia Giordano, Olivia Arnold, Diren Arda Karaoglu, Jommel Macaraeg, Kathryn Shimamoto, Arjun Dhar, Ella Postich, Hamed R. Youshanlouei, Sinan Cetin, Girish Venkataraman, Anand A. Patel, Adam DuVall, Michael W. Drazer, David T. Teachey, James L. LaBelle, Wendy Stock, Caner Saygin

Institutions: University of Chicago, Children's Hospital of Philadelphia

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: U.S. Department of Defense, American Society of Hematology, Leukemia and Lymphoma Society, Leukemia Research Foundation, National Cancer Institute, DOD Peer Reviewed Cancer Research Program

Awards: G1755622664, IMMUNOLOGIC DRIVERS OF LINEAGE BIAS IN TP53-MUTANT ACUTE LEUKEMIA, G9000372090, Cancer Center Support Grant

OpenAlex ID: W7211944319

FWCI:

Cites:

Cited by:

Related to: 10